Glycine is involved in several physiological functions, e.g. as a neurotransmitter in the central nervous system, and sarcosine has been identified as a differential metabolite greatly enhanced during prostate cancer progression and metastasis. Glycine oxidase from Bacillus subtilis (GO) was engineered with the final aim of producing specific analytical systems to detect these small achiral amino acids. Based on in silico analysis, site-saturation mutagenesis was independently performed at 11 positions: a total of 16 single-point GO variants were analyzed. Significantly improved kinetic parameters were observed on glycine for the A54R, H244K-N-Q-R, Y246W and M261R variants. The introduction of multiple mutations then identified the H244K/M261R variant showing a 5.4-fold increase in maximal activity on glycine. With sarcosine as substrate, a number of single-point variants showed increased maximal activity and/or affinity: the kinetic efficiency was increased 6-fold for the M49L variant. Two GO variants with a high substrate specificity ratio for glycine (versus sarcosine, i.e. H244K GO) or for sarcosine (versus glycine, i.e. M49L GO) combined with high substrate affinity were used to set up a simple fluorescence-based biosensor. This optical sensing assay represents a novel, inexpensive and fast tool to assay glycine or sarcosine concentrations in biological samples (detection limit ≤ 0.5 lM).
IntroductionGlycine is the smallest and the only nonchiral natural a-amino acid used for protein biosynthesis. In addition to such a structural role, it possesses further physiological functions: it is an important biosynthetic precursor (i.e. it is used for de novo synthesis of porphyrins and purines) and it acts as a neurotransmitter in the central nervous system. Glycine is a coagonist, together with D-serine, of glutamate at glutamatergic N-methyl-Daspartate receptors (NMDARs) in the forebrain [1], thus serving both inhibitory and excitatory functions [2]. Due to this role, glycine is probably involved in the pathophysiology of schizophrenia and other neurological diseases. For example, a correlation exists between low levels of glycine and catatonia (a psychiatric disease), and the perturbation of the glycine deportation system is associated with ifosfamide encephalopathy and congenital nonketotic hyperglycinemia [2].Sarcosine, 2-(methylamino)acetic acid or N-methylglycine, is a natural, small, endogenous amino acid present in low concentrations in the blood and in urine. It has been proposed to play a role in the progression of prostate cancer, and assessing sarcosine concentrations in body fluids was suggested as a novel biomarker for prostate cancer [3]. With the final aim of developing a biosensor to assay glycine and sarcosine in biological fluids, we engineered glycine oxidase from Bacillus subtilis (GO) (EC 1.4.3.19) to improve its kinetic efficiency on these two compounds. GO is a homotetrameric flavoenzyme that contains one molecule of noncovalently bound FAD per 47 kDa protein monomer [4,5]. Purified recomb...